Human papillomavirus type 16 E6 protein transcriptionally modulates fibronectin gene expression by induction of protein complexes binding to the cyclic AMP response element

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4310-4318

  Shino, Yuji ^a   Shirasawa, Hiroshi ^a   Kinoshita, Tomoaki ^a   Simizu, Bunsiti ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; FIBRONECTIN; ONCOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; WART VIRUS;

EID: 0030912197     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4310-4318.1997     Document Type: Article

References (58)

1. Adams, J. C., and F. M. Watt. 1984. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature (London) 340:307-309.
2. Akutsu, N., H. Shirasawa, T. Asano, K. Isono, and B. Simizu. 1996. p53-dependent and -independent transactivation by the E6 protein of human papillomavirus type 16. J. Gen. Virol. 77:459-463.
3. Allen-Hoffmann, B. L., S. J. Schlosser, W. H. Brondyk, and W. E. Fahl. 1990. Fibronectin levels are enhanced in human fibroblasts overexpressing the c-sis protooncogene. J. Biol. Chem. 265:5219-5225.
4. Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun proto-oncogene is positively autoregulated by its product, Jun-AP-1. Cell 55:875-885.
5. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
6. Benbrook, D. M., and N. C. Jones. 1990. Heterodimer formation between CREB and JUN proteins. Oncogene 5:295-302.
7. Bowlus, C. L., J. J. McQuillan, and D. C. Dean. 1991. Characterization of three different elements in the 5′-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP. J. Biol. Chem. 266:1122-1127.
8. Brower, M., D. N. Carney, H. K. Oie, A. F. Gazdar, and J. D. Minna. 1986. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 46:798-806.
9. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Crook, T., J. A. Tidy, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547-556.
11. Dean, D. C., M. S. Blakeley, R. F. Newby, P. Ghazal, L. Henninghausen, and S. Bourgeois. 1989. Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol. Cell. Biol. 9:1498-1506.
12. Dean, D. C., J. J. McQuillan, and S. Weintraub. 1990. Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element. J. Biol. Chem. 265:3522-3527.
13. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
14. Desaintes, C., S. Hallez, P. V. Alphen, and A. Burny. 1992. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 66:325-333.
15. Dignam, J., R. Lebovitz, and R. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
16. Du, W., D. Thanos, and T. Maniatis. 1993. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74:887-898.
17. Fagen, J. B., M. E. Sobel, K. M. Yamada, B. de Crombrugghe, and I. Pastan. 1981. Effect of transformation on fibronectin gene expression using cloned fibronectin cDNA. J. Biol. Chem. 256:520-525.
18. Foster, S. A., G. W. Demers, B. G. Etscheid, and D. A. Galloway. 1994. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68:5698-5705.
19. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
20. Hai, T., F. Liu, W. J. Coukos, and M. R. Green. 1989. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3:2083-2090.
21. Hai, T., and T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724.
22. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV 16 E6 and E7 proteins cooperate to immortalize primary human foreskin keratinocytes. EMBO J. 8:3905-3910.
23. Howley, P. M. 1996. Papillomavirinae: the viruses and their replication, p. 2045-2076. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
24. Hudson, J. B., M. A. Bedell, D. J. McCance, and L. A. Laiminis. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64:519-526.
25. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:775-784.
26. Hynes, R. O., and K. M. Yamada. 1982. Fibronectins: multifunctional modular glycoproteins. J. Cell Biol. 95:369-377.
27. Hynes, R. O. 1990. Fibronectins. Springer-Verlag, New York, N.Y.
28. Ignotz, R. A., and J. Massagué. 1986. Transforming growth faclor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:4337-4345.
29. Jochemsen, A. G., R. Bernards, H. J. van Kranen, A. Houweling, J. L. Bos, and A. J. van der Eb. 1986. Different activities of the adenovirus type 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene. J. Virol. 59:684-691.
30. Kim, S.-J., S. Wagner, F. Liu, M. A. O'Reilly, P. D. Robbins, and M. R. Green. 1992. Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature (London) 358:331-334.
31. Kinoshita, T., H. Shirasawa, Y. Shino, K. Shimizu, H. Moriya, and B. Shimizu. 1996. Human papillomavirus type 16 E6 protein up-regulates the expression of the high mobility group protein HMG-I(Y) gene in mouse 10T1/2 cells. Virus Res. 42:119-125.
32. Lechner, M. S., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045-3052.
33. Lehn, H., P. Krieg, and G. Sauer. 1985. Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. Proc. Natl. Acad. Sci. USA 82:5540-5544.
34. Liu, F., and M. R. Green. 1990. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell 61:1217-1224.
35. Lorincz, A. T., R. Richard, A. B. Jenson, M. D. Greenberg, W. Lancaster, and R. J. Kurman. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337.
36. Matsunaga, T., H. Shirasawa, M. Tanabe, N. Ohnuma, H. Takahashi, and B. Simizu. 1993. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas. Cancer Res. 53:3179-3185.
37. McCarthy, J. B., M. L. Basara, S. L. Palm, D. F. Sas, and L. T. Furcht. 1985. The role of cell adhesion proteins - laminin and fibronectin - in the movement of malignant and metastatic cells. Cancer Metastasis Rev. 4:125-152.
38. Minden, A., A. Lin, T. Smeal, B. Derijard, M. Cobb, R. Davis, and M. Karin. 1994. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup hut not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14:6683-6688.
39. Munger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
40. Nakajima, T., T. Nakamura, S. Tsunoda, S. Nakada, and K. Oda. 1992. E1A-responsive elements for repression of rat fibronectin gene transcription. Mol. Cell. Biol. 12:2837-2846.
41. Polly, P., and R. C. Nicholson. 1993. Sequence of the mouse fibronectin-encoding gene promoter region. Gene 137:353-354.
42. Ryseck, R.-P., and R. Bravo. 1991. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene 6:533-542.
43. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
44. Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523-5527.
45. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
46. Sedman, S. A., M. S. Barbosa, W. C. Vass, N. L. Hubbert, J. A. Haas, D. R. Lowy, and J. T. Schiller. 1991. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol. 65:4860-4866.
47. Sheibani, N., J. S. Rhim, and B. L. Allen-Hoffmann. 1991. Malignant human papillomavirus type 16-transformed human keratinocytes exhibit altered expression of extracellular matrix glycoproteins. Cancer Res. 51:5967-5975.
48. Shimizu, K., H. Shirasawa, M.-H. Jin, N. Inaba, S. Sekiya, and B. Simizu. 1994. Alternative splicing of human papillomavirus type-16 E6-mRNA in mouse and monkey cell lines. Int. J. Oncol. 4:971-976.
49. Shirasawa, H., Y. Tomita, S. Sekiya, H. Takamizawa, and B. Simizu. 1987. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J. Gen. Virol. 68:583-591.
50. Shirasawa, H., Y. Tomita, K. Kubota, T. Kasai, S. Sekiya, H. Takamizawa, and B. Simizu. 1988. Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J. Virol. 62:1022-1027.
51. Shirasawa, H., M.-H. Jin, K. Shimizu, N. Akutsu, Y. Shino, and B. Simizu. 1994. Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16. Virology 203:36-42.
52. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83:4680-4684.
53. Suzuki, M., C. Kuroda, E. Oda, S. Tsunoda, T. Nakamura, T. Nakajima, and K. Oda. 1995. G10BP, an E1A-inducible negative regulator of Sp1, represses transcription of the rat fibronectin gene. Mol. Cell. Biol. 15:5423-5433.
54. Takahashi, T., M. M. Nau, I. Chiba, M. J. Birrer, R. K. Rosenberg, M. Vinocour, M. Levitt, H. Pass, A. F. Gazdar, and J. D. Minna. 1989. p53: a frequent target for genetic abnormalities in lung cancer. Science 246:491-494.
55. van Dam, H., M. Duyndam, R. Rottier, A. Bosch, L. de Vries-Smits, P. Herrlich, A. Zantema, P. Angel, and A. J. van der Eb. 1993. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:479-487.
56. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
57. Westwick, J. K., A. D. Cox, C. J. Der, M. H. Cobb, M. Hibi, M. Karin, and D. A. Brenner. 1994. Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc. Natl. Acad. Sci. USA 91:6030-6034.
58. Yamada, K. M. 1983. Cell surface interactions with extracellular materials. Annu. Rev. Biochem. 52:761-799.